Janus Henderson Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.3M Buy
3,451,628
+1,355,640
+65% +$22.5M 0.03% 358
2025
Q4
$27.7M Buy
2,095,988
+2,084,888
+18,783% +$24.6M 0.01% 533
2025
Q3
$79.5K Hold
11,100
﹤0.01% 2394
2025
Q2
$524K Hold
11,100
﹤0.01% 1927
2025
Q1
$442K Hold
11,100
﹤0.01% 2023
2024
Q4
$600K Hold
11,100
﹤0.01% 1947
2024
Q3
$560K Hold
11,100
﹤0.01% 1980
2024
Q2
$487K Sell
11,100
-187
-2% -$7.92K ﹤0.01% 2001
2024
Q1
$567K Buy
11,287
+65
+0.6% +$3.53K ﹤0.01% 1945
2023
Q4
$677K Sell
11,222
-110
-1% -$5.67K ﹤0.01% 1853
2023
Q3
$646K Buy
+11,332
New +$626K ﹤0.01% 1798
2021
Q4
Sell
-15,168
Closed -$150K 2572
2021
Q3
$150K Sell
15,168
-33,095
-69% -$330K ﹤0.01% 2113
2021
Q2
$497K Hold
48,263
﹤0.01% 1433
2021
Q1
$493K Sell
48,263
-101,737
-68% -$1.12M ﹤0.01% 1355
2020
Q4
$1.66M Buy
+150,000
New +$1.59M ﹤0.01% 1152

Other funds holding MLTX